Anti-mag neuropathy
Clinical trials for Anti-mag neuropathy explained in plain language.
Never miss a new study
Get alerted when new Anti-mag neuropathy trials appear
Sign up with your email to follow new studies for Anti-mag neuropathy, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare nerve disease: rituximab trial targets good responders
Disease control Recruiting nowThis phase 3 trial tests whether the drug rituximab can improve disability in people with anti-MAG neuropathy, a rare nerve condition that causes progressive weakness and numbness. The study will enroll 90 participants who have had the disease for 5 years or less and have shown r…
Matched conditions: ANTI-MAG NEUROPATHY
Phase 3 • Sponsor: Centre Hospitalier Universitaire de Saint Etienne • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New study aims to unravel nerve mysteries in rare diseases
Knowledge-focused Recruiting nowThis study looks at how nerves work in people with Charcot-Marie-Tooth disease and other nerve disorders like CIDP. Researchers will use special electrical tests and ultrasound to measure nerve and muscle changes. The goal is to better understand these conditions, not to test a n…
Matched conditions: ANTI-MAG NEUROPATHY
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:00 UTC